Work

Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer

Year: 2016

Type: editorial

Abstract: In the castration-resistant state, androgen receptor (AR)-signaling remains a critical driver of prostate cancer cell growth. This realization led to the development of the next-generation AR-direc...

Source: Expert Opinion on Therapeutic Targets

DOI: 10.1517/14728222.2016.1159676

Authors: M. T. Schweizer, S. R. Plymate

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, National Institutes of Health, National Cancer Institute, Congressionally Directed Medical Research Programs

Awards: G2477279009, G302247320, Targeting the Aberrant Androgen Receptor in Advanced Treatment-Resistant Prostate Cancer, G5379335500, G6686147195, G9000206974, G9000214175, Androgen Receptor Action in Castration Resistant Prostate Cancer, The Pacific Northwest Prostate Cancer SPORE

OpenAlex ID: W2292731076

Cites: 30

Cited by: 9

Related to: 10